Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Prokidney (PROK) EBITDA: 2020-2024

Historic EBITDA for Prokidney (PROK) over the last 5 years, with Dec 2024 value amounting to -$183.7 million.

  • Prokidney's EBITDA rose 21.31% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$171.2 million, marking a year-over-year decrease of 9.53%. This contributed to the annual value of -$183.7 million for FY2024, which is 21.22% down from last year.
  • Prokidney's EBITDA amounted to -$183.7 million in FY2024, which was down 21.22% from -$151.5 million recorded in FY2023.
  • In the past 5 years, Prokidney's EBITDA registered a high of -$27.0 million during FY2020, and its lowest value of -$183.7 million during FY2024.
  • In the last 3 years, Prokidney's EBITDA had a median value of -$153.0 million in 2022 and averaged -$162.7 million.
  • As far as peak fluctuations go, Prokidney's EBITDA crashed by 177.64% in 2022, and later grew by 0.97% in 2023.
  • Yearly analysis of 5 years shows Prokidney's EBITDA stood at -$27.0 million in 2020, then slumped by 103.93% to -$55.1 million in 2021, then plummeted by 177.64% to -$153.0 million in 2022, then rose by 0.97% to -$151.5 million in 2023, then dropped by 21.22% to -$183.7 million in 2024.